Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kelo-Cell is a specialized dermatology company focused on advanced scar management and skin regeneration solutions. The company's flagship product line utilizes a unique Bi-Phase technology that combines medical-grade silicone with plant stem cell extracts, specifically from Centella asiatica. This dual-action approach is designed to provide an occlusive barrier that hydrates the skin while simultaneously delivering botanical actives to modulate collagen production and reduce inflammation. Kelo-Cell products are primarily indicated for the treatment and prevention of hypertrophic and keloid scars resulting from surgery, trauma, or aesthetic procedures. The brand is part of the Oystershell Laboratories portfolio and is distributed internationally to healthcare professionals and pharmacies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KELO.CELL.